3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Ovarian Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Lymphoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Carcinoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Fallopian Tube Neoplasms
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Esophageal Neoplasms
1
Interventions
abemaciclib
3
Fulvestrant
3
Anastrozole
3
ribociclib
2
palbociclib
2
exemestane
2
Tamoxifen
2
Letrozole
2
trastuzumab deruxtecan
1
taxane
1
pertuzumab
1
elacestrant
1
dalpiciclib
1
Trastuzumab
1
STX-478
1
RAD1901
1
Metformin
1
Leflunomide
1
Imlunestrant
1
Gonadotropin-Releasing Hormone
1
Genotype
1
Body Height
1
Blood Pressure
1
AZD9833
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Diseases
×
ipatasertib
×
90 days
×
Clear all
No trials found.